article_snippet: The scientists, who estimate treating the disease identified two biomarkers in the urine which The scientists, who estimate treating the disease believe can predict a patient's prognosis.
article_snippet: Their identified two markers in urine, by analysing  specimens provided by volunteers.
article_snippet: Two prognostic urinary biomarkers were identified - epidermal growth factor receptor (EGFR) and a protein, epithelial cell adhesion molecule (EpCAM).
article_snippet: Two prognostic urinary biomarkers were identified - epidermal growth factor receptor (EGFR) and a protein, epithelial cell adhesion molecule (EpCAM) concluded therefore that measuring Two prognostic urinary biomarkers, could 'represent a simple and useful approach for fast-tracking the investigation and treatment of patients with the most aggressive bladder cancers'.
article_snippet: Two prognostic urinary biomarkers were identified - epidermal growth factor receptor (EGFR) and a protein, epithelial cell adhesion molecule (EpCAM) said the tests could prove useful for both newly-diagnosed patients as well as existing patients, who suffer a recurrence of the disease.
article_snippet: Two prognostic urinary biomarkers were identified - epidermal growth factor receptor (EGFR) and a protein, epithelial cell adhesion molecule (EpCAM) concluded therefore that measuring the biomarkers, could 'represent a simple and useful approach for fast-tracking the investigation and treatment of patients with the most aggressive bladder cancers'.
article_snippet: Two prognostic urinary biomarkers were identified - epidermal growth factor receptor (EGFR) and a protein, epithelial cell adhesion molecule (EpCAM) said the tests could prove useful for both newly-diagnosed patients as well as existing patients, who suffer a recurrence of the disease.
article_snippet: It comes as researchers at the University of Birmingham have identified two biomarkers in simple urine tests that could help doctors determine a patient's prognosis, therefore helping to develop tailored treatment plans.
article_snippet: Rik Bryan, from the University of BirminghamBirmingham, said: 'These biomarkers alone cannot be used to diagnose bladder cancer, but there is immense value in being able to easily and independently indicate the prognosis of the disease in order to guide treatment and decide whether more or less aggressive management is required.'